Merus N.V.
MRUSDelisted Dec 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651311
Merus N.V. was delisted on Dec 30, 2025; its insiders filed their last Form 4 on Dec 30, 2025; 268 institutions reported holding it in 13F filings for Q3 2025, worth $6.70B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Merus N.V. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 103 | +40 |
| Shares | 22.2M | 36.7K | 33.0M | +10.9M (+49.1%) |
| Value | $487.8M | $808.0K | $1.05B | +$562.3M (+115.5%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (43)
Institutions that held Merus N.V. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (3)
Institutions that held Merus N.V. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Avoro Capital Advisors LLC | 450,000 | $9.90M |
| Healthcare of Ontario Pension Plan Trust Fund | 59,100 | $1.30M |
| Candriam Luxembourg S.C.A. | 47 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Merus N.V. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 36,743 | $808.0K |